Do you want to read an article? Please log in or register.
Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma
Asthma
RECOMMENDED
Related content
RECOMMENDED
Asthma
Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function
Respir Med.
Mansur AH, Srivastava S, Sahal A
doi: 10.1016/j.rmed.2018.08.005.
IgE sensitisation to food allergens and airborne allergens in relation to biomarkers of type 2 inflammation in asthma
Clin Exp Allergy.
Patelis A, Alving K, Middelveld R, James A, Ono J, Ohta S, Izuhara K, Borres MP, Forsberg B, Janson C, Malinovschi A
doi: 10.1111/cea.13165.
RECOMMENDED
Asthma
Treatment options in type-2 low asthma
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Hinks TS, Levine SJ, Brusselle GG
doi: 10.1183/13993003.00528-2020.
RECOMMENDED
Asthma
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type-2 Inflammation
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Kolmert J, Gómez C, Balgoma D, Sjödin M, Bood J, Konradsen JR, Ericsson M, Thörngren JO, James A, Mikus M, Sousa AR, Riley JH, Bates S, Bakke PS, Pandis I, Caruso M, Chanez P, Fowler SJ, Geiser T, Howarth P, Horváth I, Krug N, Montuschi P, Sanak M, Behndig A, Shaw DE, Knowles RG, Holweg CTJ, Wheelock ÅM, Dahlén B, Nordlund B, Alving K, Hedlin G, Chung KF, Adcock IM, Sterk PJ, Djukanovic R, Dahlén SE, Wheelock CE, U-BIOPRED Study Group
doi: 10.1164/rccm.201909-1869OC.
COMMENTED
Asthma
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Mansur AH, Fowler SJ, Niven RM, Howarth PH, Lordan JL, Menzies-Gow A, Harrison TW, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID, investigators for the MRC Refractory Asthma Stratification Programme.
doi: 10.1016/S2213-2600(20)30397-0.
Asthma
A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma
Meltzer EO, Berger WE
doi: 10.2500/aap.2018.39.4103.
RECOMMENDED
Asthma
Meeting the Challenge of Identifying New Treatments for Type 2-low Neutrophilic Asthma
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Kalchiem-Dekel O, Yao X, Levine SJ
doi: 10.1016/j.chest.2019.08.2192.
Diagnosis and Management of Asthma in Adults: A Review
JAMA.
McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ
doi: 10.1001/jama.2017.8372.
Sleep Apnea
Aiding sleep in type 2 diabetes: therapeutic considerations
Lancet Diabetes Endocrinol.
Tan X, van Egmond L, Chapman CD, Cedernaes J, Benedict C
doi: 10.1016/S2213-